NewGen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to treat cancer patients.

Our pipeline includes pre-clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs.

Our strategy is to identify and in-license programs, add value by completing pre-clinical development and then partnering with pharmaceutical companies to initiate clinical development and market approved products. In addition, we seek to collaborate with leading pharmaceutical and biotechnology companies to discover and develop drug candidates across a broad range of therapeutic areas.

Download Corporate Presentation  (PDF, 3.4MB)

 

 

NEWS & EVENTS

8/10/2015: NewGen Granted Composition of Matter patent for NT-113


CONTACT INFORMATION

Corporate Headquarters:
3475 Edison Way, Suite R
Menlo Park, CA 94025
+1.650.995.7508